IN2015DN00634A - - Google Patents

Info

Publication number
IN2015DN00634A
IN2015DN00634A IN634DEN2015A IN2015DN00634A IN 2015DN00634 A IN2015DN00634 A IN 2015DN00634A IN 634DEN2015 A IN634DEN2015 A IN 634DEN2015A IN 2015DN00634 A IN2015DN00634 A IN 2015DN00634A
Authority
IN
India
Prior art keywords
aptamers
present disclosure
disclosure relates
specifically bind
demonstrate superior
Prior art date
Application number
Inventor
Wei Duan
Original Assignee
Univ Deakin
Wei Duan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2012903332A external-priority patent/AU2012903332A0/en
Application filed by Univ Deakin, Wei Duan filed Critical Univ Deakin
Publication of IN2015DN00634A publication Critical patent/IN2015DN00634A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/16—Aptamers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/33—Chemical structure of the base
    • C12N2310/334—Modified C
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/33—Chemical structure of the base
    • C12N2310/335—Modified T or U
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/351—Conjugate
    • C12N2310/3517—Marker; Tag
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/30—Special therapeutic applications
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present disclosure relates to RNA aptamers and uses thereof in particular aptamers which specifically bind to CD133 and which demonstrate superior tumour penetration.
IN634DEN2015 2012-08-02 2013-08-02 IN2015DN00634A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2012903332A AU2012903332A0 (en) 2012-08-02 CD133 Aptamers for Detection of Cancer Stem Cells
PCT/AU2013/000850 WO2014019024A1 (en) 2012-08-02 2013-08-02 Cd133 aptamers for detection of cancer stem cells

Publications (1)

Publication Number Publication Date
IN2015DN00634A true IN2015DN00634A (en) 2015-06-26

Family

ID=50026987

Family Applications (1)

Application Number Title Priority Date Filing Date
IN634DEN2015 IN2015DN00634A (en) 2012-08-02 2013-08-02

Country Status (16)

Country Link
US (1) US9840712B2 (en)
EP (1) EP2880185B1 (en)
JP (1) JP6279573B2 (en)
KR (1) KR20150085806A (en)
CN (1) CN104781417B (en)
AU (1) AU2013299331B2 (en)
BR (1) BR112015002289A2 (en)
CA (1) CA2880589A1 (en)
ES (1) ES2741949T3 (en)
IL (1) IL237034A0 (en)
IN (1) IN2015DN00634A (en)
MX (1) MX2015001433A (en)
NZ (1) NZ704719A (en)
SG (1) SG11201500666TA (en)
WO (1) WO2014019024A1 (en)
ZA (1) ZA201501318B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015213483B2 (en) 2014-02-05 2020-07-02 Deakin University Aptamer construct
KR101612272B1 (en) 2014-06-20 2016-04-15 한양대학교 산학협력단 Peptide for Detection of Glioma Stem Cell
EP3256593B1 (en) 2015-02-11 2020-03-25 Deakin University Epcam aptamers and conjugates thereof
CN104745590A (en) * 2015-03-23 2015-07-01 莱萌科医疗技术有限公司 Nucleic acid aptamer capable of detecting ENOX2 protein in serum of cancer patient and application thereof
KR101726212B1 (en) * 2015-05-08 2017-04-13 한양대학교 산학협력단 Multi Peptide Conjugated Probe for Detecting of CD133
CN105602904B (en) * 2015-08-24 2019-05-31 天津市第四中心医院 The new application of CD133 plasmid
KR20190023197A (en) 2017-08-28 2019-03-08 피엠씨씨 주식회사 recombinant expression vector for detection of cancer stem cells and transfected cell line and manufacturing method thereof
EP3753427A4 (en) 2018-02-13 2021-09-08 Shenzhen Smoore Technology Limited Electronic cigarette and heating assembly and heating member thereof
CN108866061A (en) * 2018-06-21 2018-11-23 中山大学附属第五医院 A kind of aptamer identifying liver cancer cells and its screening technique and purposes
CN108866062A (en) * 2018-06-21 2018-11-23 中山大学附属第五医院 The DNA aptamers and its screening technique of a kind of specific recognition liver-cancer stem cell and application
CN109536503B (en) * 2018-12-06 2021-03-02 浙江省肿瘤医院 Aptamer combined with CD133 protein in targeted manner and screening method and application thereof
KR102212149B1 (en) * 2019-03-28 2021-02-04 부산대학교 산학협력단 Aptamer specifically binding to cancer stem cell and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637459A (en) * 1990-06-11 1997-06-10 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: chimeric selex
JP2763958B2 (en) 1990-06-11 1998-06-11 ネクスター ファーマスーティカルズ，インコーポレイテッド Nucleic acid ligand
US5270163A (en) 1990-06-11 1993-12-14 University Research Corporation Methods for identifying nucleic acid ligands
US6261774B1 (en) 1990-06-11 2001-07-17 Gilead Sciences, Inc. Truncation selex method
AU2003206865B2 (en) 2002-02-08 2007-10-04 D. Collen Research Foundation Vzw A novel target to inhibit angiogenesis
US20060263336A1 (en) 2003-03-24 2006-11-23 Caplan Arnold I Cell targeting methods and compositions
JP5697297B2 (en) * 2004-05-14 2015-04-08 ロゼッタ ジノミクス リミテッド Micro NAS and its use
CA2998412C (en) 2004-11-12 2024-01-02 Cambridge University Technical Services Ltd. Methods and means related to cancer stem cells
JP2007319153A (en) 2006-06-02 2007-12-13 Takashi Otsu Combination preparation of nucleic acid ligand and neutralizer
WO2009009739A2 (en) * 2007-07-12 2009-01-15 Theracrine, Inc. Methods and compositions for facilitating cell death of cancer stem cells and for treating cancer
US20110206614A1 (en) 2007-11-23 2011-08-25 Whitehead Institute For Biomedical Research Systemic instigation systems to study tumor growth or metastasis

Also Published As

Publication number Publication date
ZA201501318B (en) 2016-07-27
CA2880589A1 (en) 2014-02-06
NZ704719A (en) 2018-02-23
ES2741949T3 (en) 2020-02-12
CN104781417B (en) 2017-12-12
SG11201500666TA (en) 2015-02-27
CN104781417A (en) 2015-07-15
WO2014019024A1 (en) 2014-02-06
JP2015526075A (en) 2015-09-10
EP2880185B1 (en) 2019-07-03
US20150299708A1 (en) 2015-10-22
EP2880185A4 (en) 2016-04-06
EP2880185A1 (en) 2015-06-10
AU2013299331A1 (en) 2015-02-26
KR20150085806A (en) 2015-07-24
IL237034A0 (en) 2015-03-31
JP6279573B2 (en) 2018-02-14
AU2013299331B2 (en) 2018-07-26
BR112015002289A2 (en) 2017-07-04
MX2015001433A (en) 2015-09-16
US9840712B2 (en) 2017-12-12

Similar Documents

Publication Publication Date Title
IN2015DN00634A (en)
IN2015DN00636A (en)
HK1208163A1 (en) Drug-conjugates, conjugation methods, and uses thereof
HK1206774A1 (en) Biophotonic compositions, kits and methods
PT2877490T (en) Split inteins, conjugates and uses thereof
PT2922554T (en) Terminally modified rna
CL2015001157A1 (en) Compositions and methods to treat proteinopathies.
HK1210949A1 (en) Combinations and uses thereof
HK1199269A1 (en) Anti-asic1 antibodies and uses thereof -asic1
GB201218085D0 (en) Torrified wood briquette manufacture
EP2951300A4 (en) Robust, easy to use immobilized enzyme reactors
IL235609A0 (en) Wideband low latency repeater and methods
EP2900693A4 (en) Adcc-mediating antibodies, combinations and uses thereof
PH12016500541A1 (en) Use of odiparcil in the treatment of a mucopolysaccharidosis
HK1211323A1 (en) Dual enzymatic amplification
GB201218688D0 (en) Trading desk
AU342728S (en) Backplate for handle assembly
AU344026S (en) Bracket
GB201211978D0 (en) Enzyme
UA106373C2 (en) Use of pollentarum as an agent with frigoprotective action
TWM432402U (en) Spine activator structure